// App-Quantinova.ai

180 : Impact of Missing Anti-Cyclic Citrullinated Peptide (CCP) Antibody Serology on Clinical Outcomes in Early Rheumatoid Arthritis: Results from CATCH (Canadian Early Arthritis Cohort)

Researchers

Presenter

  • Vivian Bykerk

Principal Investigators

  • Boulos Haraoui

  • Carter Thorne

  • Edward Keystone

  • Gilles Boire

  • Carol Hitchon

  • Diane Tin

  • Janet Pope

Medical Centers

  • University of Western Ontario, London, ON, Canada

  • Toronto, ON, Canada

  • Univ of Manitoba, Winnipeg, Canada

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • Western Univeristy, London, ON, Canada

  • U of T, Toronto,Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • anti-CCP antibodies

  • Albumin/creatinine

Drug/Treatment

  • Methotrexate

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved